Tuberculosis in Kenya: a follow-up of a national sampling survey of drug resistance and other factors. An East African and British Medical Research Council co-operative investigation.
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007630:Kenya; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin